GSA CAPITAL PARTNERS LLP - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$304,000
+38.2%
16,096
-13.8%
0.04%
+64.0%
Q2 2019$220,000
+41.0%
18,681
+63.9%
0.02%
+56.2%
Q1 2019$156,000
-44.7%
11,398
+32.2%
0.02%
+14.3%
Q3 2015$282,000
-6.6%
8,622
+51.3%
0.01%
+16.7%
Q2 2015$302,000
+43.8%
5,700
-21.7%
0.01%
+50.0%
Q1 2015$210,0007,2800.01%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Novo Holdings A/S 3,201,183$40,591,0003.96%
Cormorant Asset Management, LP 150,000$1,902,0000.39%
PFM Health Sciences, LP 1,034,030$13,112,0000.30%
Partner Investment Management, L.P. 23,660$300,0000.11%
PointState Capital LP 375,000$4,755,0000.09%
Spark Investment Management LLC 38,400$486,0000.07%
SECTORAL ASSET MANAGEMENT INC 89,300$1,132,0000.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 95,722$1,214,0000.05%
CADIAN CAPITAL MANAGEMENT, LP 120,000$1,522,0000.04%
Nicholas Investment Partners, LP 49,341$626,0000.04%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders